These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7398247)

  • 1. Twenty years of haloperidol: clinical effectiveness and theoretical implications.
    Freyhan FA
    Compr Psychiatry; 1980; 21(4):251-7. PubMed ID: 7398247
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical efficacy of haloperidol in chronic psychotic patients.
    Lapolla A
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychotolysis with haloperidol. Rapid control of the acutely disturbed psychotic patient.
    Carter RG
    Dis Nerv Syst; 1977 Apr; 38(4):237-9. PubMed ID: 849701
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications.
    Zbytovský J; Zapletálek M
    Act Nerv Super (Praha); 1989 Dec; 31(4):266-7. PubMed ID: 2638106
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma haloperidol levels and clinical response: confounding variables.
    Mavroidis ML; Garver DL; Kanter DR; Hirschowitz J
    Psychopharmacol Bull; 1985; 21(1):62-5. PubMed ID: 3983340
    [No Abstract]   [Full Text] [Related]  

  • 7. [Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].
    Lemperiere T; Ropert R; Leger JM; Alexandre JY; Clerc G; Darondel A; Delaunay J; Delteil P; Malauzat D; Raynaud J
    Encephale; 1984; 10(5):217-22. PubMed ID: 6519017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled comparison of nalorphine with haloperidol in acute psychoses of the schizophrenic group ].
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Cesk Psychiatr; 1982 Jun; 78(3):159-66. PubMed ID: 6749311
    [No Abstract]   [Full Text] [Related]  

  • 9. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
    Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
    Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of depot neuroleptic haloperidol decanoate.
    Fernando J; Krishna Raju R; Jones GG; Stanley RO
    Acta Psychiatr Scand; 1984 Feb; 69(2):175-6. PubMed ID: 6702478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium and haloperidol.
    Nemes ZC; Volavka J; Cooper TB; O'Donnell J; Jaeger J
    Biol Psychiatry; 1986 May; 21(5-6):568-9. PubMed ID: 3697447
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of haloperidol in drug refractory patients.
    Ban TA; Lehmann HE
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:78-86. PubMed ID: 4383142
    [No Abstract]   [Full Text] [Related]  

  • 14. [Haloperidol in the treatment of psychotic disorders in old age].
    Kobrzyńska E; Chachaj L
    Psychiatr Pol; 1982; 16(1-2):13-7. PubMed ID: 7146202
    [No Abstract]   [Full Text] [Related]  

  • 15. [In process].
    Stiefelhagen P
    Med Monatsschr Pharm; 2016 Sep; 39(9):398-9. PubMed ID: 29956516
    [No Abstract]   [Full Text] [Related]  

  • 16. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flupenthixol versus haloperidol in acute psychosis.
    Parent M; Toussaint C
    Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient management of the acute psychotic patient: stabilization and maintenance with haloperidol.
    Garfinkel PE
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):26-31. PubMed ID: 1019144
    [No Abstract]   [Full Text] [Related]  

  • 19. A butyrophenone (haloperidol) for the treatment of institutionalized patients.
    Lapolla A; Nash LR
    Int J Neuropsychiatry; 1966 Apr; 2(2):129-34. PubMed ID: 5335397
    [No Abstract]   [Full Text] [Related]  

  • 20. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
    Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R
    Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.